302
Participants
Start Date
July 31, 2004
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
Aripiprazole tablet, 10 mg
Aripiprazole tablet 10 mg po qd x 42 days
Aripiprazole tablet, 30 mg
Aripiprazole tablet 30 mg po qd x 42 days
Placebo tablet
Placebo tablet po qd x 42 days
Local Institution, Birmingham
Local Institution, Little Rock
Local Institution, Costa Mesa
Local Institution, Los Angeles
Local Institution, National City
Local Institution, Orange
Local Institution, Pasadena
Local Institution, Sacramento
Local Institution, San Diego
Local Institution, Temecula
Local Institution, Washington D.C.
Local Institution, Altamonte Springs
Local Institution, Fort Lauderdale
Local Institution, Gainesville
Local Institution, Hialeah
Local Institution, Jacksonville
Local Institution, Miami
Local Institution, North Miami
Local Institution, Orange City
Local Institution, Tampa
Local Institution, Newnan
Local Institution, Smyrna
Local Institution, Honolulu
Local Institution, Chicago
Local Institution, Kansas City
Local Institution, Lexington
Local Institution, Lake Charles
Local Institution, New Orleans
Local Institution, Medford
Local Institution, Clinton Township
Local Institution, Flowood
Local Institution, Kansas City
Local Institution, Las Vegas
Local Institution, Elmsford
Local Institution, New York
Local Institution, Olean
Local Institution, Rochester
Local Institution, Chapel Hill
Local Institution, Cleveland
Local Institution, Lyndhurst
Local Institution, Oklahoma City
Local Institution, Bala-Cynwyd
Local Institution, Philadelphia
Local Institution, Memphis
Local Institution, Bellaire
Local Institution, DeSoto
Local Institution, Houston
Local Institution, San Antonio
Local Institution, Salt Lake City
Local Institution, Richmond
Local Institution, Kirkland
Local Institution, Spokane
Local Institution, Wauwatosa
Local Institution, Rio Piedras
Local Institution, San Juan
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY